| Term 
 | Definition 
 
        | SNS Gq Increases vascular smooth muscle contraction, increases pupillary dilator muscle contraction (mydriasis), increases intestinal and bladder sphincter muscle contraction Decreases renin release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SNS Gi Decrease SNS outflow, Decrease Insulin release, Decrease Lipolysis, Increase Plt aggregation Drugs that Block A2: Clonidine, Methyldopa, Yohimbine, Mertazapine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SNS Gs Increase HR, Increase Contractility, Increase Renin, Increase Lipolysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SNS Gs Vasodilation, Bronchodilation, Increase HR, Increase Contractility, Increase Lipolysis, Increase Insulin resistance, Increase Aqueous Humor Production Decrease Uterine tone (tocolysis); Ciliary muscle relaxation *NE has NO B2 EFFECTS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PNS Gq CNS, Enteric nervous system; Increased Gastric Motility? |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PNS Gi Decreased HR and Contractility of Atria (SA nodal tissue) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PNS Gq Increased exocrine gland secretions (i.e. lacrimal, salivary, gastric acis), Increased gut peristalsis, Increased bladder contraction, bronchconstriction, Increased pupillary sphincter muscle contraction (miosis), ciliary muscle contraction (accomodation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine Gs Relaxes renal vascular smooth muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine Gi Modulates transmitter release, especially in the brain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Histamine Gq Increased nasal and bronchial mucus production, Increased Vascular permeability, contraction of bronchioles, pruritis, and pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Histamine Gs Increased Gastric Acid Secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vasopressin Gq Increased Vascular smooth muscle contraction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vasopressin Gs Increased H2O permeability and reabsorption in the collecting tubules of the kidney (V2 is found in the 2 Kidneys) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | H1 a1, V1, M1, M3 HAVe 1 M&M IP3 DAG pathway |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAD 2's M2, a2, D2 Inhibits Adenylyl cyclase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B1, B2, D1, H2, V2 Stimulate Adenylyl cyclase |  | 
        |  | 
        
        | Term 
 
        | Drugs that bind Presynaptic A2 receptors |  | Definition 
 
        | These drugs decrease release of NE Clonidine Methyldopa Yohimbine Mirtazapine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinomimetic Use: Postoperative ileus, neurogenic ileus and urinary retention Action: Activates bowel and bladder smooth muscle; resistant to AChE. "Bethany, call (bethanechol) me, maybe, if you tant to activate your bowels and bladder." Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinomimetic agent Clinical: Glaucoma, pupillary constriction, and relief of intraocular pressure Action: Carbon copy of acetylcholine Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinomimetic agent Clinical: Potent stimulator of sweat, tears and saliva; Open-angle and closed angle glaucoma Action: Contracts ciliary muscle of eye (open-angle glaucoma), pupillary sphincter (closed-angle glaucoma); resistant to AChE. "You cry, drool, and sweat on your 'pillow'". Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinomimetic Clinical: Challenge test for diagnosis of asthma Action: Stimulates muscarine receptors in airway when inhaled.  Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChEsterase Clinical: Postpop and neurogenic ileus and urinary retention, myasthenia gravis, reversal of NMJ block (post op) Action: Increase endogenous ACh.  Neo CNS = No CNS penetration Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChEsterase Clinical: Myasthenia gravis (long acting); does not penetrate CNS Action: Increase endogenous ACh; Increase strength. Pyridostigmine gets rid of myasthenia gravis Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChEsterase Clinical: Anticholinergic toxicity (crosses blood-brain barrier -> CNS) Action: Increase endogenous ACh. Physostigmine "phyxes" atropine overdose Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChE Clinical: Alzheimer's disease Action: Increases endogenous ACh Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers Other Drugs: Rivastigmine, Galantamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChE Clinical: Alzheimer's disease Action: Increases endogenous ACh Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers Other Drugs: Donepezil, Galantamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChE Clinical: Alzheimer's disease Action: Increases endogenous ACh Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers Other Drugs: Rivastigmine, Donepezil |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AChEsterase Clinical: Historically, diagnosis of myasthenia gravis (extremely short acting). Myasthenis now diagnosed by anti-AChR Ab (anti-acetylcholine receptor antibody) test. Action: Increase endogenou ACh Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |  | 
        |  | 
        
        | Term 
 
        | Symptoms of Cholinesterase Inhibitor Poisoning |  | Definition 
 
        | DUMBBELSS (aka PNS stimulation) Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Excitation of skeletal muscle and CNS, Lacrimation, Sweating and Salivation Often due to organophosphates, such as parathion, that irreversibly inhibits AChE; found in insecticides; poisoning usually seen in farmers Antidote - atropine (competitive inhibitor) + pralidoxime (regenerates AChE if given early) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Eye Application: Produce mydriasis and cycloplegia Other Drugs: homatropine, tropicamide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Eye Application: Produce mydriasis and cycloplegia Other Drugs: Atropine, Tropicamide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Eye Application: Produce mydriasis and cycloplegia Other Drugs: Atropine, homatropine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist Organ: CNS Applications: Parkinson's disease - "Park my Benz" |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist Organ: CNS Applications: Motion Sickness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Respiratory system Application: COPD, asthma ("I pray I can breath soon!") Other Drugs: Tiotropium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Respiratory system Application: COPD, asthma ("I pray I can breath soon!") Other Drugs: Ipratropium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Genitourinary Applications: Reduce urgency in mild cystitis and reduce bladder spasms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist Organ: Gastrointestinal, respiratory Applications: -Parenteral: preoperative use to reduce airway secretions -Oral: drooling, peptic ulcer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist Use: Bradycardia, ophthalmic applications Organs: Eye=↑pupil ↑pupil dilation; Airway =↓secretions Stomach = ↓acid secretion; Gut = ↓motility; Bladder = ↓urgency in cystitis Action: blocks DUMBBeLSS Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Lacrimation, Sweating and Salivation; skeletal muscle and CNS excitation mediated by nicotinic receptors Toxicity: Hot as a hare, Dry as a bone, Red as a beet, Blind as a bat, Mad as a hatter; can be cause by Jimson weed (Datura) -> gardener's pupil (mydriasis due to plant alkaloids) Can cause acute angle-closure glaucoma in elderly (due to mydriasis), urinary retention in men with prostatic hyperplasia and hyperthermia in infants   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic Effec: B (at low dose) >a (at high dose) Applications: Anaphylaxis, open angle glaucoma, asthma, hypotension; alpha effects predominate at high doses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic a1>a2>B1 Applications: Hypotension (but ↓ renal perfusion) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic B1=B2 Applications: Electrophysiologic evaluation of tacharrhythmias. Can worsen ischemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic D1=D2>B>a Applications: Unstable bradycardia, heart failure, shock; inotropic and chronotropic a effects predominat at high doses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic B1>B2, a Applications: Heart failure (inotropic>chronotropic), cardiac stress testing |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic a1>a2 Hypotension (vasoconstrictor), ocular procedure (mydriatic), rhinitis (decongestant) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic B2>B1 Applications: Acute asthma Similar Drugs: Salmetrol, Terbutaline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic B2>B1 Applications: Long term asthma or COPD Similar drugs: Albuterol, terbutaline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic B2>B1 Applications: Reduce premature uterine contractions Similar drugs: Albuterol, Salmetrol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect sympathomimetic Effect: Indirect general agonist, reuptake inhibitor, also releases stored catecholamines Applications: Narcolepsy, obesity, ADD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Sympathomimetic Effect: Indirec general agonist, releases stored catecholamines Applications: Nasal decongestion, urinary incontinence, hypotension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect sympathomimetic Effect: Indirect general agonist, reuptake inhbitor Applications: Causes vasoconstriction and local anesthesia; never give B-blockers if cocaine intoxication is suspected (can lead to unopposed a1 activation and extreme hypertension) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympatholytic (a2-agonist) Applications: Hypertensive urgency (limited situations); does not decrease renal blood flow; ADHD, severe pain and a variety of off-label indications (e.g. ethanol and opioid withdrawal) Toxicity: CNS depression, bradycardia, hypotension, respiratory depression, and small pupil size |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympatholytic (a2-agonist) Applications: Hypertension in pregnancy, safe in pregnancy Toxicity: Direct Coombs +, hemolytic anemia, SLE-like syndrome |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective alpha blocker - irreversible Application: Pheochromocytoma (use phenoxybenzamine before removing tumor, since high levels of released catecholamines will not be able to overcome blockage) Toxicity: Orthostatic hypotension, reflex tachycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective alpha blocker - reversible Applications: Give to pts on MAOI who eat tyramine-containing foods |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a1 blocker (-zosin) Application: HTN, urinary retention in BPH Tox: 1st-dose orthostatic hypotension, dizziness, headache |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a1 blocker (-zosin) Application: HTN, urinary retention in BPH Tox: 1st-dose orthostatic hypotension, dizziness, headache |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a1 blocker (-zosin) Application: HTN, urinary retention in BPH Tox: 1st-dose orthostatic hypotension, dizziness, headache |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a2 blocker Application: Depression Tox: Sedation, ↑ serum cholestrol, ↑ appetite |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A BEAM = B1 antagonists (B1>B2) - Acebutolol (partial agonist), Betaxolol, Esmolol (Short acting), Atenolol, Metoprolol Use: HTN, angina pectoris, MI, SVT (propranolol, esmolol), CHF, Glaucoma Toxicity: impotence, exacerbation of asthma, CV effects, CNS effects (sedation, sleep alteration); use with caution in diabetics   |  | 
        |  | 
        
        | Term 
 
        | Nonselective Beta Blockers |  | Definition 
 
        | Please Try Not βeing Picky = Propranolol, Timolol, Nadolol and Pindolol Use: HTN, angina pectoris, MI, SVT (propranolol, esmolol), CHF, Glaucoma Toxicity: impotence, exacerbation of asthma, CV effects, CNS effects (sedation, sleep alteration); use with caution in diabetics |  | 
        |  | 
        
        | Term 
 
        | Nonselective (vasodilatory) alpha and beta blockers |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | PAPA = Partial B-Agonist - Pindolol, Acebutolol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a-agonist ↑ outflow of aqeuous humor Side effects: Mydriasis, stinging; do not use in closed-angle glaucoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ↓aqueous humor synthesis Side effects: No pupillary or vision changes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Timolol, betaxolol, carteolol ↓aqueous humor secretion Side effects: No pupillary or vision changes |  | 
        |  | 
        
        | Term 
 
        | Cholinomimetics for Glaucoma |  | Definition 
 
        | Pilocarpine, carbachol, physostigmine, echothiophate Mechanism: Ciliary muscle contraction, opening of trabecular meshwork; ↑ outflow of aqueous humor Side effects: Miosis, cyclospasm |  | 
        |  | 
        
        | Term 
 
        | Diuretics as Glaucoma drugs |  | Definition 
 
        | Acetazolamide, dorzolamide, brinzolamide Mechanism: decrease aqueous humor secretion due to decreased HCO3- (via inhibition of carbonic anhydrase) Side effects: No pupillary or vision changes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prostaglandin for Glaucoma Mechanism: Increased outflow of aqueous humor Side effects: Darkens color of iris (browning) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Not used clinically Competes with choline for uptake into presynaptic cleft |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Competes with ACh for packaging into vessicles |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits synaptobrevin (snare protein) inhibitng fusion of vessicles to the presynaptic membrane result is flaccid paralysis; prevents sweating too |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits conversion of Tyrosine to DOPA Decrease sympathetic outflow |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits packaging of catecholamines into presynaptic vessicles Decrease sympathetic outflow |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Replaces the Catecholamines in the presynaptic vessicles Decrease sympathetic outflow |  | 
        |  |